E
Verrica Pharmaceuticals Inc. VRCA
$5.23 -$0.12-2.24% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025
Revenue 269.35% 899.71%
Total Other Revenue -- --
Total Revenue 269.35% 899.71%
Cost of Revenue -14.00% -78.17%
Gross Profit 1,343.18% 105.92%
SG&A Expenses 0.05% -10.44%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -3.26% -0.87%
Operating Income 118.57% 28.22%
Income Before Tax 102.09% 39.87%
Income Tax Expenses -- --
Earnings from Continuing Operations 102.09% 39.87%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 102.09% 39.87%
EBIT 118.57% 28.22%
EBITDA 120.45% 28.21%
EPS Basic 102.09% 57.32%
Normalized Basic EPS 102.09% 57.10%
EPS Diluted 101.95% 57.32%
Normalized Diluted EPS 102.09% 57.10%
Average Basic Shares Outstanding 0.05% 40.86%
Average Diluted Shares Outstanding 0.07% 40.86%
Dividend Per Share -- --
Payout Ratio -- --